Inactive Instrument

Naturecell Co Ltd Share Price Korea S.E.

Equities

Pharmaceuticals

End-of-day quote Korea S.E.
- - Intraday chart for Naturecell Co Ltd

Financials

Sales 2022 21.55B 15.61M 0 1.2B Sales 2023 19.35B 14.01M 0 1.08B Capitalization 513B 371M 0 28.63B
Net income 2022 -6.81B -4.93M - -381M Net income 2023 -11.68B -8.46M - -652M EV / Sales 2022 44.1 x
Net cash position 2022 5.72B 4.14M 0 320M Net cash position 2023 27.58B 19.97M 0 1.54B EV / Sales 2023 25.1 x
P/E ratio 2022
-140 x
P/E ratio 2023
-43.5 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 80.05%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 59 28/01/16
President 51 25/03/20
President 61 15/08/13
Members of the board TitleAgeSince
Chief Executive Officer 59 28/01/16
President 61 15/08/13
President 51 25/03/20
More insiders
NatureCell Co Ltd is a Korea-based company principally engaged in the stem cell business. The Company operates its business through three segments. The Stem Cell Business segment is engaged in the development of stem cell therapeutics, the manufacture of stem cell culture media, the development and sale of stem cell culture cosmetics, and the provision of blood cell storage services, among others. The Food Business segment is engaged in the manufacture and sale of fruit beverages including tomato juice, peach juice and others, canned beverages such as sikhye, fruit concentrates and others, as well as fermentation and health functional foods. The Hygiene Business segment is engaged in the manufacture and sale of health hygiene products such as masks, disinfectants, wipes, and others.
More about the company